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The neuropathic pain is caused by the injury or damage on
the sensory nervous system; its pathological manifestations
include allodynia, hyperalgesia, and spontaneous pain. About
4–8% of people in our society are suffering from this disease.
The maladaptive plasticity refers to the plasticity in the
nervous system that leads to a disruption of the function and
may be considered as a disease state [1]. Emerging evidences
from both human patients and animal models showed that
maladaptive plastic changes happened along the sensory
pathways, from the peripheral to central nervous system,
which may contribute to the generation, development, and
maintenance of neuropathic pain. The current special issue
focused on the molecular mechanism underlying maladap-
tive plasticity along sensory pathways; different laboratories
around the world investigated the maladaptive change in
different signaling pathways at different levels; the contribu-
tions in this area will highlight the pain managements in the
future.
The transient receptor potential cation channel subfamily
V member 1 (TRPV1) is the first identified member of TRPV
proteins. TRPV1 can be activated by high temperature or
specific chemical stimuli. The activation of TRPV1 in the
terminal of nociceptive primary afferents conveys noxious
information to the spinal cord and superspinal regions.
Recent studies also identified critical roles of TRPV1 in the
central regions of pain pathway in pain regulation. In the
current issue, T. Jian et al. report that TRPV1 in dorsal root
ganglia (DRG) modulates histamine H4 receptor-mediated
itch. This finding will extend our understanding of the
mechanisms of histamine-induced itch and the interaction
of the itch and pain. S.-I. Choi et al. review recent studies
on TRPV1-regulated pain, especially pathological pain, and
suggest that TRPV1 contributes to pain maintenance. The
new data may have revealed novel insights into the roles of
spinal cord TRPV1 in regulating spinal plasticity, which may
identify a new target for modulating pathological pain.
Low back pain affects a large number of patients. Defor-
mation of DRGs and their nerve roots is implicated in the
pathogenesis. W.-J. Han et al. evaluate the analgesic effects
of a novel synthesized nitronyl (NIT) nitroxide radicals on
radicular low back pain in a rat model generated by chronic
DRG compression. The authors report a significant analgesic
effect of this agent, probably due to its antioxidation and anti-
inflammation effects. Y-.B. Xie et al. describe a new rat animal
model of human low back pain, by chronic compression
of multiple DRGs on one side of lumber. This rat model
develops spontaneous pain, cold allodynia, and hyperalgesia.
Activating transcription factor 3 (ATF3) and CGRP are
upregulated in bilateral DRG neurons and may contribute to
the expression of DRG compression-induced pain.
Matrix metalloproteinases (MMPs) play important roles
in nociception and allodynia. Q. Wang et al. report a crit-
ical role of Extracellular Matrix Metalloproteinase Inducer
(EMMPRIN)/OX47, a key regulator of MMP activities, in
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neuropathic pain development. Their studies show that SNL
leads to OX47 upregulation in ipsilateral DRG and that
downregulation of OX47 attenuates SNL-induced mechani-
cal allodynia.
Gate-control theory of pain proposed by Melzack and
Wall (1965) explains the regulation of noxious information
transmission in the spinal substantia gelatinosa. F. J. R.
Pela´ez and S. Taniguchi have revisited this theory from the
perspective of NMDA receptor-mediated synaptic plasticity
and intrinsic plasticity, and the Melzack and Wall circuit
was slightly modified by using strictly excitatory nociceptive
afferences and was further tested at different pain conditions.
Spinal microglia play critical roles in the developments
of chronic pain. A. Jurga et al. report the contribution of
TLR2 and TLR4 to neuropathic pain in a chronic constric-
tion injury (CCI) model. They describe a time-dependent
upregulation of TLR2, TLR4, MyD88, and TRIF mRNA and
protein. In addition, blockade of TLR2 and TLR4 impairs
the expression of pain behaviors and opioid analgesia. These
findings support TLR2 and TLR4 as putative targets for
developing therapeutic approaches.
J. Wang et al. report the involvements of mammalian tar-
get of rapamycin (mTOR) in the RVM, a key relay region for
the descending pathway, in regulation of neuropathic pain.
They show that phosphorylated mTOR protein increases
mainly in RVM serotonergic spinally projecting neurons in
the spared nerve injury (SNI) model. Infusion of rapamycin
decreases both excitatory synaptic transmission and intrinsic
excitability of serotonergic neurons, which may underlie the
analgesic effects. These findings suggest a novel mechanism
by which mTOR inhibitor causes analgesia.
The anterior cingulate cortex (ACC) is a heterogeneous
brain region and is involved in regulation of pain, emotion,
and sex attraction. Z.-X. Zuo et al. report that nerve ligation
leads to AChE upregulation in the ACC.They have tested the
analgesic effects of huperzine A, an alkaloid isolated from a
Chinese club-moss, on evoked pain and spontaneous pain,
and reported a significant analgesic effect on evoked pain but
not spontaneous pain, indicating a specific role of AChE in
regulation of evoked pain.
We are pleased to introduce this special issue that focuses
on themaladaptive plasticity in the pain pathway, in bothPNS
and CNS. It is becoming clear that pain-related maladaptive
changes can occur at a cellular level such as alteration of
synaptic transmission and at a molecular level such as the
dysregulation of various signaling pathways. The studies
collected in this issue will help elucidate the pathogenic
mechanism of neuropathic pain and facilitate the develop-
ment of novel strategies for the pain treatments.
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